Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma

Conclusions: Apatinib plus TACE may improve OS and prolonged TTP in the patients with advanced HCC. The clinical-radiomics nomograms, a noninvasive pretreatment prediction tool that incorporate radiomics signature and AFP, demonstrated good prediction accuracy for OS and TTP in these patients. These results indicate that the clinical-radiomics nomograms may provide novel insight for precise personalized medicine approaches in the patients with advanced HCC.PMID:33967603 | PMC:PMC8100633 | DOI:10.7150/ijms.55510
Source: International Journal of Medical Sciences - Category: Biomedical Science Authors: Source Type: research